Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04458649 · ClinicalTrials.gov registry record
Continuous Glucose Monitoring in Infants
A clinical trial of Neonatal Hypoglycemia, sponsored by University of California, San Diego.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT04458649: Recruiting study of Neonatal Hypoglycemia, sponsored by University of California, San Diego.
NCT04458649 is a study of Neonatal Hypoglycemia that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 200 participants, above the 102-participant average among 5 other Neonatal Hypoglycemia trials with a reported enrollment target (96% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04458649, a study of Neonatal Hypoglycemia, is actively recruiting participants, sponsored by University of California, San Diego.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to employ continuous glucose monitoring to measure glucose profiles in newborn infants.
Conditions Studied
Interventions
- DEVICE Dexcom continuous glucose monitor
Study Locations (1)
California
- UCSD Medical Center - La Jolla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2020-10-01 |
| Est. Completion | 2024-12-31 |
What NCT04458649 shows while recruiting
NCT04458649 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, above the 102-participant average among 5 other Neonatal Hypoglycemia trials with a reported enrollment target (96% higher).
The record links to 1 condition, with Neonatal Hypoglycemia appearing as the primary indexed condition, and to 1 intervention - of which Dexcom continuous glucose monitor is the first listed.
NCT04458649 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04458649 about?
NCT04458649 is a clinical study titled "Continuous Glucose Monitoring in Infants". The purpose of this study is to employ continuous glucose monitoring to measure glucose profiles in newborn infants.
What is the current status of trial NCT04458649?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2020-10-01. Estimated completion is 2024-12-31.
What conditions does trial NCT04458649 study?
This clinical trial studies the following conditions: Neonatal Hypoglycemia.
What interventions are being tested in trial NCT04458649?
The interventions under investigation include: Dexcom continuous glucose monitor (DEVICE).
Who is sponsoring clinical trial NCT04458649?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04458649 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neonatal Hypoglycemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Intrapartum Glucose Control and Risk of Neonatal Hypoglycemia
RECRUITING · NA
-
The Feasibility of Cream for Treatment of Neonatal Hypoglycemia
RECRUITING · NA
-
Continuous Glucose Monitoring in At-Risk Newborns
RECRUITING · NA
-
Frequency of Glucose Monitoring in Labor
COMPLETED · NA
-
Effectiveness of Donor Human Milk Supplementation for the Treatment of Hypoglycemia in the Breastfed Infant
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI